tiprankstipranks
Trending News
More News >
Gilead Sciences (GILD)
NASDAQ:GILD
US Market

Gilead Sciences (GILD) Income Statement

Compare
13,724 Followers

Gilead Sciences Income Statement

Last quarter (Q3 2025), Gilead Sciences's total revenue was $7.77B, an increase of 2.97% from the same quarter last year. In Q3, Gilead Sciences's net income was $3.05B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.75B$ 27.12B$ 27.28B$ 27.30B$ 24.69B
Gross Profit
$ 22.50B$ 20.62B$ 21.62B$ 20.70B$ 20.12B
Operating Expenses
$ 20.84B$ 13.01B$ 14.29B$ 10.79B$ 16.05B
Depreciation and Amortization
$ 2.77B$ 2.69B$ 2.10B$ 2.05B$ 1.48B
EBITDA
$ 4.43B$ 10.50B$ 8.85B$ 11.33B$ 4.13B
Operating Income
$ 1.66B$ 7.61B$ 7.33B$ 9.92B$ 4.07B
Other Income/Expenses
$ -972.00M$ -746.00M$ -1.52B$ -1.64B$ -2.40B
Pretax Income
$ 690.00M$ 6.86B$ 5.81B$ 8.28B$ 1.67B
Net Income
$ 480.00M$ 5.67B$ 4.59B$ 6.22B$ 123.00M
Per Share Metrics
Basic EPS
$ 0.38$ 4.54$ 3.66$ 4.96$ 0.10
Diluted EPS
$ 0.38$ 4.50$ 3.64$ 4.93$ 0.10
Weighted Average Shares Outstanding
1.25B 1.25B 1.25B 1.26B 1.26B
Weighted Average Shares Outstanding (Diluted)
1.25B 1.26B 1.26B 1.26B 1.26B
Currency in USD

Gilead Sciences Earnings and Revenue History